Literature DB >> 7913328

Continued drug use and other cofactors for progression to AIDS among injecting drug users.

P J Ronald1, J R Robertson, R A Elton.   

Abstract

OBJECTIVE: To evaluate the effects of continued drug use and other cofactors on progression to AIDS among HIV-infected injecting drug users.
DESIGN: A prospective study.
SETTING: The Muirhouse Medical Group in Edinburgh, Scotland, UK.
SUBJECTS: A total of 156 HIV-infected injecting drug users. MAIN OUTCOME MEASURES: Progression to AIDS and low absolute CD4 counts.
RESULTS: Of this group, 48% will have progressed to AIDS 10 years after seroconversion. Age and low absolute T4 counts had a significant effect on progression to AIDS, with older patients progressing more rapidly. Sex had no significant effects on progression. Absolute CD4+ counts and the CD4:CD8 ratio were significant predictors of progression among the group. Concurrent heroin injecting increased the risk of progression to AIDS. No significant effects were observed for use of other drugs.
CONCLUSIONS: Our findings suggest that continued drug use may have an accelerating effect on progression to AIDS. Age also had an accelerating effect on progression, but sex had no significant effects. In general, the study group did not appear to progress at a different rate from other similar groups of HIV-infected individuals, despite the fact that this was a relatively young cohort. These data were based on accurate estimates of seroconversion dates.

Entities:  

Mesh:

Year:  1994        PMID: 7913328     DOI: 10.1097/00002030-199403000-00007

Source DB:  PubMed          Journal:  AIDS        ISSN: 0269-9370            Impact factor:   4.177


  15 in total

1.  Patient perspectives on buprenorphine/naloxone: a qualitative study of retention during the starting treatment with agonist replacement therapies (START) study.

Authors:  Cheryl Teruya; Robert P Schwartz; Shannon Gwin Mitchell; Albert L Hasson; Christie Thomas; Samantha H Buoncristiani; Yih-Ing Hser; Katharina Wiest; Allan J Cohen; Naomi Glick; Petra Jacobs; Paul McLaughlin; Walter Ling
Journal:  J Psychoactive Drugs       Date:  2014 Nov-Dec

Review 2.  Opioids and HIV/HCV infection.

Authors:  Xu Wang; Ting Zhang; Wen-Zhe Ho
Journal:  J Neuroimmune Pharmacol       Date:  2011-07-14       Impact factor: 4.147

3.  Methadone enhances human immunodeficiency virus infection of human immune cells.

Authors:  Yuan Li; Xu Wang; Sha Tian; Chang-Jiang Guo; Steven D Douglas; Wen-Zhe Ho
Journal:  J Infect Dis       Date:  2001-12-14       Impact factor: 5.226

Review 4.  Role of mu-opioids as cofactors in human immunodeficiency virus type 1 disease progression and neuropathogenesis.

Authors:  Anupam Banerjee; Marianne Strazza; Brian Wigdahl; Vanessa Pirrone; Olimpia Meucci; Michael R Nonnemacher
Journal:  J Neurovirol       Date:  2011-07-07       Impact factor: 2.643

Review 5.  Drugs of abuse and HIV infection/replication: implications for mother-fetus transmission.

Authors:  Xu Wang; Wen-Zhe Ho
Journal:  Life Sci       Date:  2010-11-04       Impact factor: 5.037

6.  Inhibition of anti-HIV microRNA expression: a mechanism for opioid-mediated enhancement of HIV infection of monocytes.

Authors:  Xu Wang; Li Ye; Yu Zhou; Man-Qing Liu; Dun-Jin Zhou; Wen-Zhe Ho
Journal:  Am J Pathol       Date:  2010-12-23       Impact factor: 4.307

7.  Morphine enhances HIV infection of human blood mononuclear phagocytes through modulation of beta-chemokines and CCR5 receptor.

Authors:  Chang-Jiang Guo; Yuan Li; Sha Tian; Xu Wang; Steven D Douglas; Wen-Zhe Ho
Journal:  J Investig Med       Date:  2002-11       Impact factor: 2.895

Review 8.  Opiates, immune system, acquired immunodeficiency syndrome, and nonhuman primate model.

Authors:  Richard J Noel; Vanessa Rivera-Amill; Shilpa Buch; Anil Kumar
Journal:  J Neurovirol       Date:  2008-08       Impact factor: 2.643

9.  Prevalence and longitudinal correlates of recent exposure to fentanyl among HIV-positive people who use unregulated drugs during a community-wide overdose crisis.

Authors:  Soroush Moallef; Ekaterina Nosova; Seonaid Nolan; Nadia Fairbairn; Jane Loh; Kanna Hayashi; M-J Milloy
Journal:  AIDS Care       Date:  2021-03-25

10.  Morphine suppresses IFN signaling pathway and enhances AIDS virus infection.

Authors:  Yizhong Wang; Xu Wang; Li Ye; Jieliang Li; Li Song; Nilija Fulambarkar; Wenzhe Ho
Journal:  PLoS One       Date:  2012-02-16       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.